The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Vir Biotechnology Inc (VIR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.33, or 3.77%, to $9.09. The Vir Biotechnology Inc has recorded 32,694 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $8.76 and fluctuated between $9.34 as its day high and $8.33 as its day low. The current market capitalization of Vir Biotechnology Inc is $1.18B. A total of 2.19 million shares were traded on the day, compared to an average of 1.35M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, VIR has seen 2 BUY and 5 SELL insider trades, representing the acquisition of 3,500,000 and the disposition of 5,377,590 shares. Over the last 12 months, there were 26 BUYs and 154 SELLs from insiders. Insiders purchased 4,631,566 shares during that period but sold 11,179,681.
In the most recent transaction, SATO VICKI L sold 18,000 shares of VIR for 24.66 per share on Jun 30. After the transaction, the Director now owns 1,315,351 company shares. In a previous transaction on Jun 30, SVF Endurance (Cayman) Ltd sold 700 shares at 25.11 per share. VIR shares that 10% Owner owns now total 16,684,041.
Among the insiders who sold shares, SVF Endurance (Cayman) Ltd disposed of 89,942 shares on Jun 29 at a per-share price of $25.18. This resulted in the 10% Owner holding 16,684,741 shares of VIR after the transaction. In another insider transaction, SVF Endurance (Cayman) Ltd sold 7,010 shares at $25.10 per share on Jun 28. Company shares held by the 10% Owner now total 16,774,683.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for VIR in the last 3 months, the mean price target is $29.75 with high estimates of $95.00 and low estimates of $12.00. In terms of 52-week highs and lows, VIR has a high of $31.55 and a low of $7.72.
As of this writing, VIR has an earnings estimate of -$1.21 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.88 per share and a lower estimate of -$1.49. The company reported an EPS of -$1.06 in the last quarter, which was -21.80% lower than expectations of -$0.87.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VIR’s latest balance sheet shows that the firm has $708.14M in Cash & Short Term Investments as of fiscal 2021. There were $133.56M in debt and $341.24M in liabilities at the time. Its Book Value Per Share was $12.45, while its Total Shareholder’s Equity was $1.43B.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VIR is Buy with a score of 4.44.